ITOS ITEOS THERAPEUTICS INC Investor Conferences 8-K Filing 2024 - Clinical Data Update iTeos Therapeutics announced interim clinical data from a Phase 2 study of a cancer treatment and will discuss it in a conference call on September 16, 2024.Get access to all SEC 8-K filings of the ITEOS THERAPEUTICS INC